CGON - CG Oncology Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$87.20
DETAILS
HIGH:
$100.00
LOW:
$80.00
MEDIAN:
$85.00
CONSENSUS:
$87.20
UPSIDE:
16.78%
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue | 1.2 | 1.1 | 2.3 | 1.7 | 0 | 0.1 | 0.5 | 0.0 | 0.1 | 0.5 | 0.0 | 0.0 | 0 | 0.2 | 0 |
| Cost of Revenue | 3.9 | 3.0 | 2.9 | 1.6 | 31.3 | 27.5 | 26.8 | 19.6 | 18.5 | 0.0 | 0.0 | 11.7 | 0.0 | 7.8 | 0.0 |
| Gross Profit | (2.8) | (1.9) | (0.6) | 0.1 | (31.3) | (27.4) | (26.3) | (19.6) | (18.4) | 0.5 | (0.0) | (11.7) | (0.0) | (7.6) | (0.0) |
| Operating Expenses | |||||||||||||||
| R&D Expenses | 54.7 | 43.7 | 30.0 | 27.9 | 31.3 | 27.5 | 26.8 | 19.6 | 18.5 | 17.2 | 15.9 | 11.7 | 9.8 | 7.8 | 7.7 |
| SG&A Expenses | 29.0 | 20.8 | 18.0 | 23.3 | 17.4 | 14.8 | 11.7 | 8.7 | 7.5 | 5.8 | 3.0 | 2.3 | 2.5 | 2.1 | 1.7 |
| Other Expenses | 0 | 0 | 0.2 | 0 | (31.3) | (27.5) | (26.8) | (19.6) | (18.5) | 0 | 0 | (11.7) | (0.1) | (7.8) | 0.0 |
| Operating Expenses | 83.6 | 64.5 | 48.1 | 51.2 | 17.4 | 14.8 | 11.7 | 8.7 | 7.5 | 23.0 | 18.9 | 2.3 | 12.3 | 2.1 | 9.3 |
| Operating Income | |||||||||||||||
| Operating Income | (86.4) | (66.4) | (48.7) | (51.1) | (48.7) | (42.2) | (38.0) | (28.3) | (25.9) | (22.5) | (18.9) | (14.0) | (12.3) | (9.7) | (9.3) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 7.3 | 6.3 | 22.5 | 7.4 | 7.3 | 7.7 | 6.2 | 7.9 | 6.9 | 5.5 | 2.8 | 2.3 | 0.8 | 1.0 | 0.9 |
| Profitability | |||||||||||||||
| EBITDA | (79.1) | (59.4) | (40.5) | (43.4) | (41.3) | (34.4) | (31.8) | (20.4) | (18.9) | (16.9) | (16.1) | (11.8) | (11.6) | (8.7) | (9.5) |
| EBIT | (79.1) | (60.2) | (41.3) | (43.8) | (41.4) | (34.5) | (31.8) | (20.4) | (18.9) | (16.9) | (16.1) | (11.8) | (11.6) | (8.7) | (9.5) |
| Income Before Tax | (79.1) | (60.2) | (41.3) | (43.8) | (41.4) | (34.5) | (31.8) | (20.4) | (18.9) | (16.9) | (16.1) | (11.8) | (11.6) | (8.7) | (8.4) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (79.1) | (60.2) | (41.3) | (43.8) | (41.4) | (34.5) | (31.8) | (20.4) | (18.9) | (16.9) | (16.1) | (11.8) | (11.6) | (8.7) | (8.4) |
| Per Share Data | |||||||||||||||
| EPS (Basic) | -0.90 | -0.71 | -0.52 | -0.57 | -0.54 | -0.45 | -0.49 | -0.30 | -0.28 | -0.25 | -0.33 | -0.28 | -0.17 | -0.13 | -0.13 |
| EPS (Diluted) | -0.90 | -0.71 | -0.52 | -0.57 | -0.54 | -0.45 | -0.49 | -0.30 | -0.28 | -0.22 | -0.33 | -0.28 | -0.17 | -0.13 | -0.13 |
| Shares Outstanding | 88.2 | 84.5 | 77.3 | 76.7 | 76.2 | 76.2 | 64.8 | 67.1 | 66.6 | 66.6 | 66.6 | 66.6 | 66.6 | 66.6 | 66.6 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||||||||
| Cash & Cash Equivalents | 19.6 | 33.7 | 32.5 | 45.1 | 14.6 | 41.5 | 257.1 | 43.4 | 25.2 | 77.5 | 8.3 | 10.3 | 77.5 | (143.5) | 88.1 |
| Short-Term Investments | 1,008.6 | 1,042.5 | 709.7 | 635.1 | 646.4 | 647.0 | 484.9 | 497.3 | 527.7 | 489.0 | 179.4 | 193.5 | 489.0 | 287.0 | 55.3 |
| Net Receivables | 0.4 | 1.3 | 0.7 | 0.5 | 0.6 | 0.3 | 0.8 | 0.1 | 0.2 | 0.2 | 0.1 | 0.0 | 0 | 0 | 0.3 |
| Inventory | 1.0 | 1.5 | 1.6 | 1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 23.1 | 15.1 | 13.5 | 11.4 | 12.4 | 11.4 | 11.2 | 10.8 | 11.9 | 6.4 | 6.0 | 0.2 | 0 | 3.4 |
| Total Current Assets | 1,049.6 | 1,102.1 | 759.5 | 695.8 | 673.0 | 701.2 | 754.2 | 552.1 | 563.9 | 578.6 | 194.1 | 209.7 | 578.6 | 143.5 | 147.2 |
| Non-Current Assets | |||||||||||||||
| Property, Plant & Equipment | 20.4 | 19.6 | 19.6 | 19.5 | 1.2 | 1.3 | 0.5 | 0.3 | 0.4 | 0.4 | 0.5 | 0.6 | 0.4 | 0 | 0.5 |
| Goodwill | 10.3 | 10.3 | 10.3 | 12.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0.5 | 0.6 | 0.6 | 1.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4.7 | 2.7 | 1.7 | 0.1 | 27.2 | 25.7 | 0.1 | 0.1 | 0.1 | 0.1 | 4.7 | 1.6 | 0.1 | (143.5) | 0.0 |
| Total Non-Current Assets | 36.0 | 33.1 | 32.1 | 34.1 | 28.4 | 27.0 | 0.6 | 0.4 | 0.5 | 0.5 | 5.2 | 2.2 | 0.5 | (143.5) | 0.5 |
| Total Assets | 1,085.7 | 1,135.3 | 791.6 | 729.9 | 701.4 | 728.2 | 754.8 | 552.5 | 564.3 | 579.1 | 199.3 | 211.9 | 579.1 | 0 | 147.7 |
| Current Liabilities | |||||||||||||||
| Account Payables | 12.7 | 8.2 | 5.7 | 9.2 | 7.1 | 6.7 | 6.5 | 4.1 | 4.5 | 4.7 | 3.2 | 2.0 | 4.7 | 0 | 1.0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.6 | 0 | 0 | 0 | 9.0 |
| Deferred Revenue | 0.2 | 0.3 | 0.3 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | (0.2) | 4.7 | 9.0 | 6.6 | 4.8 | 2.8 | 0.4 | 5.0 | 2.7 | 2.0 | 0.5 | 4.4 | 0.3 | 0 | 0.2 |
| Total Current Liabilities | 47.2 | 35.2 | 30.8 | 30.5 | 30.4 | 22.6 | 21.4 | 15.6 | 11.9 | 10.0 | 14.3 | 11.7 | 10.0 | 0 | 15.4 |
| Non-Current Liabilities | |||||||||||||||
| Long-Term Debt | 3 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.5 |
| Deferred Tax Liabilities | 0.3 | 0.3 | 0.3 | 1.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.2 | 1.5 | 1.7 | 3.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0 | (125.2) | 0.4 |
| Total Non-Current Liabilities | 9.3 | 8.3 | 8.2 | 11.7 | 0.7 | 0.8 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.3 | 0.2 | (125.2) | 7.1 |
| Total Liabilities | 56.5 | 43.5 | 39.0 | 42.3 | 31.1 | 23.4 | 21.4 | 15.7 | 12.0 | 10.2 | 14.5 | 12.0 | 10.2 | (125.2) | 22.6 |
| Stockholders' Equity | |||||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0 |
| Retained Earnings | (518.2) | (439.2) | (379.0) | (337.7) | (293.9) | (252.4) | (218.0) | (186.2) | (165.8) | (146.9) | (129.9) | (113.8) | (146.9) | 0 | (81.3) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (77.7) | 0 |
| Total Stockholders' Equity | 1,029.1 | 1,091.8 | 752.6 | 687.6 | 670.4 | 704.8 | 733.4 | 536.8 | 552.4 | 568.9 | 184.8 | 199.9 | 568.9 | 125.2 | 125.2 |
| Total Liabilities & Equity | 1,085.7 | 1,135.3 | 791.6 | 729.9 | 701.4 | 728.2 | 754.8 | 552.5 | 564.3 | 579.1 | 199.3 | 211.9 | 579.1 | 125.2 | 147.7 |
| Debt Metrics | |||||||||||||||
| Total Debt | 8.8 | 7.6 | 7.0 | 7.2 | 1.0 | 1.0 | 0.2 | 0.3 | 0.4 | 0.4 | 1.0 | 0.5 | 0.4 | 0 | 15.9 |
| Net Debt | (10.8) | (26.1) | (25.5) | (37.9) | (13.6) | (40.4) | (256.8) | (43.1) | (24.8) | (77.1) | (7.2) | (9.8) | (77.1) | 143.5 | (72.2) |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Net Income | (79.1) | (60.2) | (41.3) | (43.8) | (41.4) | (34.5) | (31.8) | (20.4) | (18.9) | (16.9) | (16.6) | (11.8) | (11.6) | (8.7) | (8.4) |
| Depreciation & Amortization | 0.8 | 0.8 | 0.8 | 0.4 | 0.2 | 0.0 | 0 | 0.0 | 0.0 | 0.0 | (0.0) | 0.0 | 0.0 | 0.0 | 0.0 |
| Stock-Based Compensation | 14.3 | 6.5 | 7.2 | 7.3 | 7.0 | 5.2 | 5.0 | 2.6 | 2.2 | 1.5 | 0.8 | 0.4 | 0.2 | 0.2 | 0.1 |
| Change in Working Capital | 14.4 | (5.8) | (4.0) | (2.9) | 8.7 | 0.5 | 4.9 | 3.4 | 3.0 | (8.4) | 2.2 | 0.2 | 0.3 | 0.4 | 1.3 |
| Other Non-Cash Items | 3.1 | 1.7 | 1.0 | 0.0 | (2.4) | (0.5) | 1.2 | (1.6) | (2.5) | (2.2) | (2.4) | 0.3 | 0.4 | 0.1 | 0.1 |
| Operating Cash Flow | (46.4) | (56.9) | (36.2) | (38.9) | (28.0) | (29.3) | (20.7) | (15.9) | (16.1) | (26.0) | (16.1) | (10.8) | (10.8) | (8.0) | (6.8) |
| Investing Activities | |||||||||||||||
| Capital Expenditure | (0.5) | (0.3) | (0.0) | (0.1) | (0.0) | (0.0) | (0.2) | 0.0 | (0.0) | (0.0) | 0 | 0.0 | (0.0) | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | (22.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (196.0) | (587.4) | (297.7) | (240.3) | (168.0) | (361.9) | (217.1) | (169.2) | (206.3) | (453.3) | (379.5) | (192.1) | (32.3) | (78.7) | (55.3) |
| Sales/Maturities of Investments | 226.9 | 252.9 | 222.2 | 251.4 | 170.4 | 200.1 | 228.2 | 201.2 | 170.1 | 145.9 | 0 | 30.7 | 135.7 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 26 | (1) | (25) | 0 | 0 | 0 | 0 | 396.4 | (1.4) | 0 | 0 | 0 |
| Investing Cash Flow | 30.4 | (334.8) | (75.5) | 15.0 | 1.4 | (186.8) | 10.9 | 32.0 | (36.2) | (307.4) | 16.9 | (162.8) | 103.4 | (78.7) | (55.3) |
| Financing Activities | |||||||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0.4 | 0 | 0 | (0.4) | (0.0) | (0.1) | (15.4) | (0.8) | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 391.3 | (0.2) | 0 | 5.4 | 0 | 0 | (0.4) | 0 | 0 | (3.4) | 0.3 | (0.3) | 0 | 0 | 0 |
| Financing Cash Flow | 1.9 | 393.0 | 99.1 | 54.4 | (0.3) | 0.5 | 223.4 | 2.2 | 0.0 | 402.7 | (2.9) | 105.9 | (15.2) | (0.8) | 56.7 |
| Cash Position | |||||||||||||||
| Net Change in Cash | (14.1) | 1.2 | (12.7) | 30.5 | (26.8) | (215.6) | 213.7 | 18.3 | (52.3) | 69.2 | (2.0) | (67.8) | 77.3 | (87.5) | (5.5) |
| Cash at Beginning | 33.7 | 32.5 | 45.1 | 14.6 | 41.5 | 257.1 | 43.4 | 25.2 | 77.5 | 8.3 | 10.3 | 78.0 | 0.7 | 88.1 | 93.6 |
| Cash at End | 19.6 | 33.7 | 32.5 | 45.1 | 14.6 | 41.5 | 257.1 | 43.4 | 25.2 | 77.5 | 8.3 | 10.3 | 78.0 | 0.7 | 88.1 |
| Free Cash Flow | (46.9) | (57.2) | (36.2) | (39.0) | (28.0) | (29.3) | (20.9) | (15.9) | (16.1) | (26.0) | (16.1) | (10.8) | (10.8) | (8.0) | (6.8) |
| Key Metrics | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||
| Revenue | 1.2 | 1.1 | 2.3 | 1.7 | 0 | 0.1 | 0.5 | 0.0 | 0.1 | 0.5 | 0.0 | 0.0 | 0 | 0.2 | 0 |
| Gross Profit | (2.8) | (1.9) | (0.6) | 0.1 | (31.3) | (27.4) | (26.3) | (19.6) | (18.4) | 0.5 | (0.0) | (11.7) | (0.0) | (7.6) | (0.0) |
| Operating Income | (86.4) | (66.4) | (48.7) | (51.1) | (48.7) | (42.2) | (38.0) | (28.3) | (25.9) | (22.5) | (18.9) | (14.0) | (12.3) | (9.7) | (9.3) |
| Net Income | (79.1) | (60.2) | (41.3) | (43.8) | (41.4) | (34.5) | (31.8) | (20.4) | (18.9) | (16.9) | (16.1) | (11.8) | (11.6) | (8.7) | (8.4) |
| EPS (Diluted) | -0.90 | -0.71 | -0.52 | -0.57 | -0.54 | -0.45 | -0.49 | -0.30 | -0.28 | -0.22 | -0.33 | -0.28 | -0.17 | -0.13 | -0.13 |
| Balance Sheet | |||||||||||||||
| Cash & Equivalents | 19.6 | 33.7 | 32.5 | 45.1 | 14.6 | 41.5 | 257.1 | 43.4 | 25.2 | 77.5 | 8.3 | 10.3 | 77.5 | (143.5) | 88.1 |
| Total Assets | 1,085.7 | 1,135.3 | 791.6 | 729.9 | 701.4 | 728.2 | 754.8 | 552.5 | 564.3 | 579.1 | 199.3 | 211.9 | 579.1 | 0 | 147.7 |
| Total Debt | 8.8 | 7.6 | 7.0 | 7.2 | 1.0 | 1.0 | 0.2 | 0.3 | 0.4 | 0.4 | 1.0 | 0.5 | 0.4 | 0 | 15.9 |
| Stockholders' Equity | 1,029.1 | 1,091.8 | 752.6 | 687.6 | 670.4 | 704.8 | 733.4 | 536.8 | 552.4 | 568.9 | 184.8 | 199.9 | 568.9 | 125.2 | 125.2 |
| Cash Flow | |||||||||||||||
| Operating Cash Flow | (46.4) | (56.9) | (36.2) | (38.9) | (28.0) | (29.3) | (20.7) | (15.9) | (16.1) | (26.0) | (16.1) | (10.8) | (10.8) | (8.0) | (6.8) |
| Capital Expenditure | (0.5) | (0.3) | (0.0) | (0.1) | (0.0) | (0.0) | (0.2) | 0.0 | (0.0) | (0.0) | 0 | 0.0 | (0.0) | 0 | 0 |
| Free Cash Flow | (46.9) | (57.2) | (36.2) | (39.0) | (28.0) | (29.3) | (20.9) | (15.9) | (16.1) | (26.0) | (16.1) | (10.8) | (10.8) | (8.0) | (6.8) |